FDA Inspection
CorneaGen - RichmondCorneaGen - Richmond – FDA Inspection, Jun 13, 2011
Record Details
This FDA Inspection record concerns CorneaGen - Richmond, with an inspection on June 13, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CorneaGen - Richmond
- Inspection Date
- June 13, 2011
- Product Type
- Biologics
View Company Profile
ID · 7fefc635-1cbd-4d8e-afec-d941322c6b37
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 729194
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.55(d)(1)(i)Documentation of CD testing and labs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CorneaGen - Richmond
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 31, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 12, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 12, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CorneaGen - Richmond
- FDA Inspection 1059878 - 2018-05-31
- FDA Inspection 974353 - 2016-05-12
- FDA Inspection 823345 - 2013-02-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.